AstraZeneca PLC Equity-NMS: AZN

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Error in Fetching Data, Please retry later.
Previous close :$72.22
Open :$75.62
Today's high :$75.7
Today's low :$73.87
52W low :$61.8831
52W high :$86.4638
EPS(TTM): :2.25
Shares O/S :3.1 B
Market cap :229.27 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
AstraZeneca PLC $73.95 -1.3% 32.27 229.27B

Frequently Asked Questions

What is the share price of AstraZeneca PLC today?

AstraZeneca PLC (AZN) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About AstraZeneca PLC

AstraZeneca PLC is a science-led biopharmaceutical company. It discovers, develops, and commercializes prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and immune therapies. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex, Faslodex and others. Its rare diseases products include Soliris, Ultomiris, Strensiq and Kanuma. Its biopharmaceuticals products include Farxiga, Crestor, Breztri and others. Its investigational vaccine candidate IVX-A12, which targets both respiratory syncytial virus and human metapneumovirus. Its oncology candidate includes FPI-2265 targeting prostate specific membrane antigen for metastatic castration resistant prostate cancer, which is in a Phase II trial. It also discovers, develops, and manufactures T-cell receptor therapies. Its Eneboparatide is an investigational therapeutic peptide.